Abstract
Finding new treatment-shortening antibiotics to improve cure rates and curb the alarming emergence of drug resistance is the major objective of tuberculosis (TB) drug development. Using a matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging suite in a biosafety containment facility, we show that the key sterilizing drugs rifampicin and pyrazinamide efficiently penetrate the sites of TB infection in lung lesions. Rifampicin even accumulates in necrotic caseum, a critical lesion site where persisting tubercle bacilli reside1. In contrast, moxifloxacin, which is active in vitro against a subpopulation of Mycobacterium tuberculosis that persists in specific niches under drug pressure and has achieved treatment shortening in mice2, does not diffuse well in caseum, concordant with its failure to shorten therapy in recent clinical trials. We suggest that such differential spatial distribution and kinetics of accumulation in lesions may create temporal and spatial windows of monotherapy in specific niches, allowing the gradual development of multidrug-resistant TB. We propose an alternative working model to prioritize new antibiotic regimens based on quantitative and spatial distribution of TB drugs in the major lesion types found in human lungs. The finding that lesion penetration may contribute to treatment outcome has wide implications for TB.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hoff, D.R. et al. Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment. PLoS ONE 6, e17550 (2011).
Li, S.Y. et al. Evaluation of moxifloxacin-containing regimens in pathologically distinct murine tuberculosis models. Antimicrob. Agents Chemother. 59, 4026–4030 (2015).
Fox, W., Ellard, G.A. & Mitchison, D.A. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications. Int. J. Tuberc. Lung Dis. 3, S231–S279 (1999).
Mitchison, D.A. The action of antituberculosis drugs in short-course chemotherapy. Tubercle 66, 219–225 (1985).
Lenaerts, A.J. et al. Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910. Antimicrob. Agents Chemother. 51, 3338–3345 (2007).
Lakshminarayana, S.B. et al. Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents. J. Antimicrob. Chemother. 70, 857–867 (2015).
Nuermberger, E.L. et al. Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. Am. J. Respir. Crit. Care Med. 169, 421–426 (2004).
Gillespie, S.H. et al. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. N. Engl. J. Med. 371, 1577–1587 (2014).
Jindani, A. et al. High-dose rifapentine with moxifloxacin for pulmonary tuberculosis. N. Engl. J. Med. 371, 1599–1608 (2014).
Dartois, V. The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat. Rev. Microbiol. 12, 159–167 (2014).
Via, L.E. et al. Host-mediated bioactivation of pyrazinamide: implications for efficacy, resistance, and therapeutic alternatives. ACS Infect. Dis. 1, 203–214 (2015).
Via, L.E. et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and non-human primates. Infect. Immun. 76, 2333–2340 (2008).
Zhang, Y., Scorpio, A., Nikaido, H. & Sun, Z. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J. Bacteriol. 181, 2044–2049 (1999).
Canetti, G. The Tubercle Bacillus in the Pulmonary Lesion of Man: Histobacteriology and Its Bearing on the Therapy of Pulmonary Tuberculosis (Springer, 1955).
Aber, V.R. & Nunn, A.J. Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy [in French]. Bull. Int. Union Tuberc. 53, 276–280 (1978).
Chang, K.C., Leung, C.C., Yew, W.W., Ho, S.C. & Tam, C.M. A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am. J. Respir. Crit. Care Med. 170, 1124–1130 (2004).
Prideaux, B. & Stoeckli, M. Mass spectrometry imaging for drug distribution studies. J. Proteomics 75, 4999–5013 (2012).
Reyzer, M.L. & Caprioli, R.M. MALDI-MS-based imaging of small molecules and proteins in tissues. Curr. Opin. Chem. Biol. 11, 29–35 (2007).
Tischler, A.D. & McKinney, J.D. Contrasting persistence strategies in Salmonella and Mycobacterium. Curr. Opin. Microbiol. 13, 93–99 (2010).
Michot, J.M., Seral, C., Van Bambeke, F., Mingeot-Leclercq, M.P. & Tulkens, P.M. Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages. Antimicrob. Agents Chemother. 49, 2429–2437 (2005).
Kjellsson, M.C. et al. Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions. Antimicrob. Agents Chemother. 56, 446–457 (2012).
Prideaux, B. et al. High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions. Anal. Chem. 83, 2112–2118 (2011).
Irwin, S.M. et al. Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas. Antimicrob. Agents Chemother. 58, 4026–4034 (2014).
Pichugin, A.V., Yan, B.S., Sloutsky, A., Kobzik, L. & Kramnik, I. Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts. Am. J. Pathol. 174, 2190–2201 (2009).
Kell, D.B. & Oliver, S.G. How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion. Front. Pharmacol. 5, 231 (2014).
Baik, J. & Rosania, G.R. Macrophages sequester clofazimine in an intracellular liquid crystal-like supramolecular organization. PLoS ONE 7, e47494 (2012).
Nathan, C. & Barry, C.E. III. TB drug development: immunology at the table. Immunol. Rev. 264, 308–318 (2015).
Rastogi, N. et al. Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis. 11, 901–907 (1992).
Calver, A.D. et al. Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerg. Infect. Dis. 16, 264–271 (2010).
Merker, M. et al. Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients. PLoS ONE 8, e82551 (2013).
Sun, G. et al. Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients. J. Infect. Dis. 206, 1724–1733 (2012).
Lee, J. et al. Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs. Antimicrob. Agents Chemother. 58, 11–18 (2014).
O'Connell, M.L. et al. Lung manifestations in an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial disease. Chest 141, 1203–1209 (2012).
Okumura, M. et al. Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern. Med. 47, 1465–1472 (2008).
Yuan, M.K. et al. Comparative chest computed tomography findings of non-tuberculous mycobacterial lung diseases and pulmonary tuberculosis in patients with acid fast bacilli smear-positive sputum. BMC Pulm. Med. 14, 65 (2014).
Wagner, C., Sauermann, R. & Joukhadar, C. Principles of antibiotic penetration into abscess fluid. Pharmacology 78, 1–10 (2006).
Robichaud, G., Garrard, K.P., Barry, J.A. & Muddiman, D.C. MSiReader: an open-source interface to view and analyze high resolving power MS imaging files on Matlab platform. J. Am. Soc. Mass Spectrom. 24, 718–721 (2013).
Schramm, T. et al. imzML—a common data format for the flexible exchange and processing of mass spectrometry imaging data. J. Proteomics 75, 5106–5110 (2012).
Via, L.E. et al. Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [18F]2-fluoro-deoxy-d-glucose positron emission tomography and computed tomography. Antimicrob. Agents Chemother. 56, 4391–4402 (2012).
MacCarrick, M.J. et al. Does hypercapnia ameliorate hyperoxia-induced lung injury in neonatal rats? Lung 188, 235–240 (2010).
Subbian, S. et al. Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response. Open Biol. 1, 110016 (2011).
Waters, N.J., Jones, R., Williams, G. & Sohal, B. Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. J. Pharm. Sci. 97, 4586–4595 (2008).
Acknowledgements
We thank D. Young and the funders of the Grand Challenge for Global Health (GCGH 11) consortium for their faith and support. We are grateful to the subjects who enrolled in the study; Y. Kim, M.S. Kong, Y. Cai, J. Gonzales and L. Goldfeder; and the clinical teams at the three Korean centers (Asan Medical Centre, Pusan National University Hospital, and the National Medical Center) for their efforts in making the study a success. We thank S. Dorman, D. Alland and H. Boshoff for sharing clinical MIC and in vitro MAC data sets, M. Stoeckli and D. Staab for providing access to the MALDI imaging platform at the Novartis Institutes for Biomedical Research, E. Eugenin, J. Flynn and J. Mattila for sharing images of M. tuberculosis in nonhuman primate lesions, and T. Dick for discussions and advice. This work was carried out with funding from US National Institutes of Health (NIH) grant 1R01AI106398-01 (V.D.), grant OPP1066499 (V.D.) from the Bill and Melinda Gates Foundation, the Intramural Research Program of the NIH National Institute of Allergy and Infectious Diseases (C.E.B.) and the National Heart, Lung and Blood Institute (K.N.O.), as well as funding from the Korean Centers for Disease Control of the Korean Ministry of Health and Welfare to the International Tuberculosis Research Center.
Author information
Authors and Affiliations
Contributions
B.P. and P.-Y.C. developed all MALDI MSI methods and imaged the study drugs in lung biopsies; L.E.V., C.E.B., S.N.C. and V.D. conceived the study and wrote the clinical protocol; L.E.V. and S.E. developed the dissection protocol and conducted lung dissections; M.D.Z. and F.K. quantified all study drugs in plasma, lung and lesions; J.S., P.O'B., D.M.W. and F.K. developed methods to sterilize TB-infected samples and extract the study drugs; J.S. and C.C. developed the caseum binding and macrophage uptake assay and quantified the study drugs; T.S. collated clinical and radiological data and facilitated sample collection and transport; M.L. coordinated patient enrollment, confirmed study eligibility and facilitated case reporting; T.S.S., J.S.C., W.K., S.N.C. and K.N.O. coordinated lung resection surgeries; C.E.B. and V.D. wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–12 and Supplementary Tables 1–3 (PDF 2334 kb)
Supplementary Data 1
Concentration of study drugs in plasma (XLSX 28 kb)
Supplementary Data 2
Concentration of study drugs in uninvolved lung (XLSX 31 kb)
Source data
Rights and permissions
About this article
Cite this article
Prideaux, B., Via, L., Zimmerman, M. et al. The association between sterilizing activity and drug distribution into tuberculosis lesions. Nat Med 21, 1223–1227 (2015). https://doi.org/10.1038/nm.3937
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3937
This article is cited by
-
Differential distribution of linezolid in diseased and nondiseased bones in patients with spinal tuberculosis
BMC Infectious Diseases (2024)
-
Lipid droplets: a cellular organelle vital in cancer cells
Cell Death Discovery (2023)
-
Predictions of Bedaquiline and Pretomanid Target Attainment in Lung Lesions of Tuberculosis Patients using Translational Minimal Physiologically Based Pharmacokinetic Modeling
Clinical Pharmacokinetics (2023)
-
A case report of persistent drug-sensitive pulmonary tuberculosis after treatment completion
BMC Infectious Diseases (2022)
-
Mass spectrometry imaging: new eyes on natural products for drug research and development
Acta Pharmacologica Sinica (2022)